Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
International Maternal Pediatric Adolescent AIDS Clinical Trials Group · with University of Colorado, Denver, Centers for Disease Control and Prevention · NCT07293559
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 1150
- US sites recruiting
- 2
- Study start
- February 24, 2026
- Record last updated
- March 27, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
IMPAACT 2046/UPLIFT (Understanding Practices of Lactation and Infant Feeding decisions Together with women with HIV) is a multi-site, mixed-methods, observational cohort study. The purpose of the study is to explore infant feeding preferences, practices, and outcomes among mothers with HIV and their families in the United States. It will employ both qualitative and quantitative research methods to address existing knowledge gaps and to understand the clinical, behavioral, and social factors influencing infant feeding decisions. As part of the study's mixed method approach, a longitudinal cohort study of mothers and their infants will be established. The study also aims to pilot a national registry of breastfeeding women living with HIV in the United States.
Being studied: No intervention provided in this study
Conditions: HIV-1-infection; Breastfeeding; Pregnancy Related
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Core Activity 1 Inclusion Criteria: Pregnant and Postpartum Women with HIV
- Is of legal age or circumstance to provide independent informed consent
- Belongs to one of the following five categories:
- Is pregnant with a gestational age of 28 0/7 to 37 6/7 weeks at entry and is considering breastfeeding
- Is pregnant with a gestational age of 28 0/7 to 37 6/7 weeks at entry and is not considering breastfeeding
- Gave birth to a live born infant after 28 February 2023, is over 4 weeks postpartum, did not breastfeed for any duration and has no intent to breastfeed
- Gave birth to a live born infant after 28 February 2023, is over 4 weeks postpartum, breastfed for less than four weeks, and has weaned
- Gave birth to a live born infant after 28 February 2023, is over 4 weeks postpartum, and breastfed for four weeks or longer
- Diagnosed with HIV prior to or during the pregnancy
- If preferred language is other than English, is willing to participate in interviews with an available translator.
Core Activity 1 Inclusion Criteria: Healthcare Providers and Ancillary Healthcare Professionals
- Is of legal age or circumstance to provide independent informed consent
- Is a healthcare provider who self-identifies as an obstetrician, midwife, nurse, adult or pediatric infectious disease specialist, or advance practice provider who participated in the care of at least five PPWH and/or their infants over the three years prior to entry OR
- Is an ancillary healthcare professional who self-identifies as a social worker, lactation support provider, patient navigator, pharmacist, doula who participated in the care of at least five PPWH and/or their infants over the three years prior to entry
Core Activity 1 Inclusion Criteria: Influential Individuals
- Has been identified by a PPWH enrolled in Core Activity 1 as aware of her HIV status and contributing to her infant feeding decisions
- Is of legal age or circumstance to provide independent informed consent
- If preferred language is other than English, is willing to participate in interviews with an available translator.
Core Activity 2 Inclusion Criteria: Pregnant and Postpartum Women with HIV and their Infant
- Is of legal age or circumstance to provide independent informed consent
- Is pregnant with singleton fetus with a gestational age of ≥ 28 0/7 weeks at entry OR
- Gave birth to a live born, singleton infant up to 7 days prior to entry
- Diagnosed with HIV prior to or during the pregnancy
- Expected to be available for the duration of follow-up
Core Activity 3 Inclusion Criteria: Breastfeeding Postpartum Women with HIV and their Infant
- Is of legal age or circumstance to provide independent informed consent
- Must be up to 7 days postpartum with live-born infant
- Diagnosed with HIV prior to or during the pregnancy
- Breastfed her infant for any duration
Core Activity 3 Inclusion Criteria: Pilot Registry Testers
- Is of legal age or circumstance to provide independent informed consent
- Working at a healthcare facility that provides care for women with HIV who are breastfeeding and/or their infants
Exclusion Criteria: Core Activities 1-3
- Has any condition identified during the screening period that, in the opinion of site investigator, would preclude informed consent, make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives
Recruiting US locations
University of Colorado, Denver (CRS 5052)
Aurora, CO 80045
Site contact: Christiana Smith-Anderson, MD, PhD · 303-724-4483 · Christiana.smith@childrenscolorado.org
Lurie Children's Hospital of Chicago (CRS 4001)
Chicago, IL 60614
Site contact: Jennifer Jao · 312-227-4080 · JJao@luriechildrens.org
Study contacts (from the official record)
- Lisa Levy · 202-884-8480 · llevy@fhi360.org
Similar studies in Colorado
All pregnancy studies in Colorado →- RecruitingHealthy volunteersPhase 1
Maternal Choline Supplementation and Cannabis Use During Pregnancy: Impact on Early Brain Development
University of Colorado, Denver
- Location
- Aurora, CO
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingHealthy volunteersPhase 3
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
Pfizer
- Location
- Aurora, CO + 76 other US sites
- Eligibility basics
- Ages 0 mo+
- RecruitingHealthy volunteersPhase 3
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Pfizer
- Location
- Aurora, CO + 111 other US sites
- Eligibility basics
- Ages 0 mo–49
- RecruitingPhase 3
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Ascendis Pharma A/S
- Location
- Aurora, CO + 21 other US sites
- Eligibility basics
- Ages 2–17